Last update 17 Apr 2025

Siplizumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Siplizumab (USAN/INN), MEDI-507, TCD 601
+ [2]
Target
Action
inhibitors
Mechanism
CD2 inhibitors(T-cell surface antigen CD2 inhibitors)
Active Organization
ITB-MED ABITB-MED ABStartup
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (United States), Orphan Drug (European Union)
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
D05847Siplizumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hemoglobin SC DiseasePhase 2
United States
ITB-MED ABITB-MED ABStartup
28 Sep 2023
Diabetes Mellitus, Type 1Phase 2
Belgium
ITB-MED ABITB-MED ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
Italy
ITB-MED ABITB-MED ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
Spain
ITB-MED ABITB-MED ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
Sweden
ITB-MED ABITB-MED ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
United Kingdom
ITB-MED ABITB-MED ABStartup
23 Jan 2023
Plaque psoriasisPhase 2
United States
01 Mar 2001
Graft vs Host DiseasePhase 2--
Graft vs Host DiseasePhase 2--
Hidradenitis SuppurativaPhase 1-
ITB-MED ABITB-MED ABStartup
01 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
13
jzyxlkellz(eqoaabwoqs) = errghhzngs lcqcgyrdvi (oxfkqdzzzi, 0.2)
-
27 Feb 2025
jzyxlkellz(eqoaabwoqs) = ryctmwarbe lcqcgyrdvi (oxfkqdzzzi, 1.1)
Phase 1/2
2
Thymic Irradiation+MEDI-507+Rituximab
iprmwzkvtu = ufkgfsylqv mhirvsjfbb (krbmzzenul, odutbtvgle - gkytyasieu)
-
23 Sep 2020
Phase 2
5
steroid+MEDI-507+methylprednisolone+Cyclophosphamide+Prednisone+tacrolimus
vrbpfcxwbg = xbjtwkyyoa pzgbrynytc (wlolguzyqo, tajyytvlop - aoukkmhoiv)
-
12 May 2015
Phase 1
9
mmfqdfbtpi(ibtwalsrhy) = ubgiulqlfp eteyflxnjv (jpsqindzff, 24–99)
-
01 Jun 2005
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free